Over‐expression of fHbp in Arabdopsis for development of meningococcal serogroup B subunit vaccine

Due to lack of commercial vaccine against the serogroup B (MenB) of Neisseria meningitides, the incidence of meningococcal disease remains high. To solve the issue, transgenic plants are used as bioreactors to produce a plant‐derived fHbp subunit vaccine. In this study, the fHbp gene was optimized according to the codon usage bias of Arabidopsis thaliana, synthesized artificially, cloned into an expression vector, driven by a seed‐specific promoter, and introduced into A. thaliana by Agrobacterium‐mediated floral‐dip transformation. Transgenic plants were identified by glufosinate selection, quickstix strips for PAT/bar tests and PCR analysis. The five plants showing higher expression of recombinant fHbp were screened through indirect ELISA. Southern blot analysis showed that the transgenic line rHF‐22 had a single‐copy integration and the highest expression of fHbp. Recombinant fHbp was purified from seeds of rHF‐22 by nitrilotriacetic acid‐mediated affinity chromatography, and the purity was 82.5%. BALB/c mice were tested for fHbp vaccine protection from lethal MenB infection, and the relative percent survival was found to be 80%. This study indicates that the recombinant fHbp produced from seeds of rHF‐22 is a potential candidate for commercial MenB vaccine. It also provides a reference for safe, cheap and large‐scale production of other plant‐made vaccines.